Search results
Novavax's stock surges almost 300% in the past month
AOL· 8 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA ...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga· 6 days agoOn Friday, the FDA approved Moderna Inc’s MRNA mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine to protect adults aged 60 and older from lower respiratory ...
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 7 hours agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 1 day agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
First human death in Mexico from H5N2 influenza strain adds to bird flu anxiety
The Telegraph via Yahoo News· 12 hours agoScientists are scrambling to understand the rapidly evolving bird flu situation in North America, as...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KTBS Shreveport· 6 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s RSV arsenal in the fall. Moderna’s shot is the third ...
Everything Congress SHOULD HAVE Asked Fauci About COVID-19 | News Talk 99.5 WRNO | The Glenn Beck...
iHeartRadio· 4 days agoWith Dr. Fauci testifying before a House subcommittee on the origins of COVID-19, many thought he...
Harlingen receives updated COVID-19 boosters, to begin administrating Friday
KRGV Rio Grande Valley· 2 days agoThe booster shot will be available at a clinic from 1 p.m. to 7 p.m. at the Harlingen Health...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines - WTOP News
WTOP Washington· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoBiotech stock hit a two-year high in February, but have trended lower in the months since despite a...